SuPAR in major depression: Association with 26 weeks antidepressant response and 10-year depression outcomes-Reference-Cited by-同舟云学术

SuPAR in major depression: Association with 26 weeks antidepressant response and 10-year depression outcomes

Published:2023-11 Issue: Volume:33 Page:100685
ISSN:2666-3546
Container-title:Brain, Behavior, & Immunity - Health
language:en
Short-container-title:Brain, Behavior, & Immunity - Health

Author:

Haupt T.H.,Elfving B.,Eugen-Olsen J.,Mors O.,Köhler-Forsberg O.

Funder

European Commission

Sixth Framework Programme

European Commission Sixth Framework Programme

Publisher

Elsevier BV

Subject

Nephrology

Reference46 articles.

1. Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy;Andersen;J. Med. Virol.,2008

2. Increased focal adhesion kinase- and urokinase-type plasminogen activator receptor-associated cell signaling in endothelial cells exposed to asbestos;Barchowsky;Environ. Health Perspect.,1997

3. Autoimmune diseases and severe infections as risk factors for mood disorders: a nationwide study;Benros;JAMA Psychiatr.,2013

4. Increased plasma level of soluble urokinase plasminogen activator receptor is associated with incidence of heart failure but not atrial fibrillation;Borné;Eur. J. Heart Fail.,2014

5. Usefulness of suPAR in the risk stratification of patients with sepsis admitted to the emergency department;Casagranda;Intern. Emerg. Med.,2015

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations between soluble urokinase plasminogen activator receptor (suPAR) concentration and psychiatric disorders – A systematic review and meta-analysis;Brain, Behavior, and Immunity;2024-08

2. Systemic concentrations of IL-18, TFG-, RANTES, ICAM-1 and uPAR as combined pathway-related factors may help in identification of patients suffering from depressive disorder;Archives of Medical Science;2024-02-02